Searching for methods to predict septic complications in surgical patients

Cover Page

Cite item

Full Text

Abstract

Aim. To assess the significance of acute stage reactants as the marker for purulent complications in surgical patients.

Methods. We analyzed the results of treatment of 228 patients with purulent and inflammatory diseases of soft tissues, treated in 2011-2014. Acute phase reactants: C-reactive protein, albumin and fibrinogen were measured starting from the day of admission and surgical treatment and during the next 7 days. The control group (112 patients) included patients whowere treated conventionally by gauze bandage with water-soluble ointments and antiseptic solutions and broad-spectrum antibiotics. In the study group (116 patients) topical treatment of wounds was performed using «Poliderm» bandages.

Results. Application of the «Poliderm» combined dressing reduced the wounds clearance term from 4.3±0.5 to 3.2±0.4 days, active inflammation term from 8.8±1.3 to 6.4±0.7 days, epithelialization of the wound from 10.1±0.8 to 8.4±0.6 days. C-reactive protein level was 87.3±4.3 g/l at the day of admission and decreased by day 7 to 34.13±1.2 g/l, compared to 51.83±3.6 g/l on the 7th day in the control group. Albumin level was 42.73±3.7 g/l in the study group with further decrease to 40.33±1.7 g/l on the 2nd and subsequent increase up to 45.13±1.3 g/l on the day 7. Patients of the control group had albumin level decreased on the 2nd and 3rd days with further increase up to 41.73±2.1 g/l on the day 7. At the treatment start, leukocyte intoxication index was 5.923±0.4 in the main group and 5.873±0.3 in the control group. On the 2nd day, this parameter decreased to 5.12 in the main group and to 5.41 in the control group.

Conclusion. Measuring the levels of acute phase reactants (C-reactive protein, albumin, etc.) allows to assess the clinical course of a purulent and inflammatory disease, to register the good treatment effect on the 1-2nd day of treatment, even before the significant clinical changes, changes in the body temperature, white blood cell counts, erythrocyte sedimentation rate.

About the authors

T Z Zakiev

Medical and sanitary unit of JSC «Tatneft» and the city of Almetyevsk, Almetyevsk, Russia

Author for correspondence.
Email: zakievtz@rambler.ru

S R Tuysin

Bashkir State Medical University, Ufa, Russia

Email: zakievtz@rambler.ru

A R Gil’fanov

Bashkir State Medical University, Ufa, Russia

Email: zakievtz@rambler.ru

R D Sagdiev

Bashkir State Medical University, Ufa, Russia

Email: zakievtz@rambler.ru

I V Zakieva

Bashkir State Medical University, Ufa, Russia

Email: zakievtz@rambler.ru

References

  1. Абаев Ю.К. Современные особенности хирургической инфекции // Вестн. хир. им. И.И. Грекова. - 2005. - Т. 164, №3. - С. 107-111.
  2. Гостищев В.К., Афанасьев А.Н. Стандарты лечебно-диагностических мероприятий у больных диабетической остеоартропатией и гнойно-некротическими поражениями стоп // Сборник статей конференции «Стандарты диагностики и лечения в гнойной хирургии». - М., 2001. - С. 107-112.
  3. Кузин М.И., Костюченок Б.М. Раны и раневая инфекция: руководство для врачей. 2-е изд., перераб. и доп. - М.: Медицина, 1990. - 361 с.
  4. Ляпунов Н.Я., Даценко Б.М., Мохерт Н.А. и др. Теория и практика местного лечения ран (проблемы лекарственной терапии). - Киев: Здоров’я, 1995. - 190 с.
  5. Туйсин С.Р. Лабораторные маркёры развития гнойно-септических осложнений в хирургии // Соврем. наукоёмк. технол. - 2012. - №4. - С. 21-23.
  6. Шевченко О.В., Вельков В.В. С-реактивный белок - «золотой маркёр», многозначительный и незаменимый. - Пущино, 2005 - 45 с.

© 2015 Zakiev T.Z., Tuysin S.R., Gil’fanov A.R., Sagdiev R.D., Zakieva I.V.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies